Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
Provided By GlobeNewswire
Last update: Sep 4, 2024
MONTREAL and CHARLOTTE, N.C., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced the appointment of Joseph Papa to its Board of Directors (“Board”), effective September 3, 2024.
